Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This is a randomized controlled trial (RCT) to test a novel artificial intelligence (AI)-enabled electrocardiogram (ECG)-based screening tool for improving the diagnosis and management of Atrial Fibrillation.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Intervention | Experimental | Patients randomized to intervention will have access to the screening tool. |
|
| Control | No Intervention | Patients randomized to control will continue routine practice. |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| AI-enabled ECG-based Screening Tool | Other | Primary care clinicians in the intervention group had access to the report, which displayed whether the AI-ECG result was positive or negative. The system will send a message to corresponding physicians if positive finding. |
| Measure | Description | Time Frame |
|---|---|---|
| Proportion of taking AF treatment medications | defined as use of long-term NOAC (apixaban, rivaroxaban, endoxaban, dabigatran). | Within 90 days |
| Proportion of ischemic Stroke | After performing an electrocardiogram, the patient's physical conditions is tracked. | Within 90 days |
| Measure | Description | Time Frame |
|---|---|---|
| Proportion of cardiologist consultation | Cardiovascular outpatient visit after discovering atrial fibrillation. | Within 90 days |
| Proportion of new-onset AF diagnosis | Atrial fibrillation diagnosis in medical records |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| National Defense Medical Center | Taipei | 114 | Taiwan |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 40611485 | Derived | Liu WT, Lin C, Lee CC, Chang CH, Fang WH, Tsai DJ, Lin WY, Hung Y, Chen KC, Lee CH, Tsai TN, Lin WS, Hung YJ, Lin SH, Tsai CS, Lin CS. Artificial Intelligence-Enabled ECGs for Atrial Fibrillation Identification and Enhanced Oral Anticoagulant Adoption: A Pragmatic Randomized Clinical Trial. J Am Heart Assoc. 2025 Jul 15;14(14):e042106. doi: 10.1161/JAHA.125.042106. Epub 2025 Jul 3. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Within 90 days |
| Proportion of echocardiogram performed after ECGs | After performing the ECG examination, perform the echocardiography examination. | Within 90 days |
| Proportion of new-onset heart failure | After performing an electrocardiogram, the patient's medical record is tracked. | Within 90 days |
| Proportion of gastrointestinal bleeding | After performing an electrocardiogram, the patient's medical record is tracked. | Within 90 days |
| Proportion of hemorrhagic stroke | After performing an electrocardiogram, the patient's medical record is tracked. | Within 90 days |
| Proportion of all cause mortality(death) | After performing an electrocardiogram, the patient's survival is tracked. | Within 90 days |